Shirin Dashtbin
Impact in
-
- Antibiotic Use and Resistance
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Clostridium difficile and Clostridium perfringens research
Papers in
-
- Clostridium difficile and Clostridium perfringens research 2
- COVID-19 Clinical Research Studies 2
-
- Urinary Tract Infections Management 2
- Co-authors
- Roya Ghanavati (7 shared papers)Marzie Mahdizade Ari (3 shared papers)Kamran Tari (1 shared paper)Ali Salimi Jeda (1 shared paper)Mehdi Salari (1 shared paper)Rokhsareh Mohammadzadeh (1 shared paper)Ali Teimoori (1 shared paper)Rasoul Yousefimashouf (1 shared paper)
In The Last Decade
Shirin Dashtbin
18 papers receiving 425 citations
Peers
Comparison fields: 5 of 89
- Applied Microbiology and Biotechnology 66
- Infectious Diseases 168
- Molecular Medicine 35
- Small Animals 46
- Critical Care and Intensive Care Medicine 23
Countries citing papers authored by Shirin Dashtbin
This map shows the geographic impact of Shirin Dashtbin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shirin Dashtbin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shirin Dashtbin more than expected).
Fields of papers citing papers by Shirin Dashtbin
This network shows the impact of papers produced by Shirin Dashtbin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shirin Dashtbin. The network helps show where Shirin Dashtbin may publish in the future.
Co-authors
The 25 scholars most cited alongside Shirin Dashtbin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 214 | |
| 2 | 2022 | 49 | |
| 3 | 2023 | 42 | |
| 4 | 2021 | 35 | |
| 5 | 2023 | 25 | |
| 6 | 2022 | 15 | |
| 7 | 2023 | 11 | |
| 8 | 2024 | 9 | |
| 9 | 2023 | 9 | |
| 10 | 2024 | 8 | |
| 11 | 2024 | 5 | |
| 12 | 2022 | 5 | |
| 13 | 2024 | 4 | |
| 14 | 2022 | 2 | |
| 15 | 2023 | 2 | |
| 16 | 2024 | 2 | |
| 17 | 2022 | 1 | |
| 18 | 2022 | 1 | |
| 19 | 2024 | 0 | |
| 20 | 2022 | 0 |
About Shirin Dashtbin
Shirin Dashtbin is a scholar working on Infectious Diseases, Epidemiology, Molecular Biology, Microbiology and Molecular Medicine, having authored 20 papers that have together received 439 indexed citations. Recurring topics across this work include Antimicrobial Peptides and Activities (2 papers), Clostridium difficile and Clostridium perfringens research (2 papers), Urinary Tract Infections Management (2 papers), Antibiotic Resistance in Bacteria (2 papers), Antibiotic Use and Resistance (2 papers), COVID-19 Clinical Research Studies (2 papers), Streptococcal Infections and Treatments (1 paper) and S100 Proteins and Annexins (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (66 citations), Infectious Diseases (168 citations), Molecular Medicine (35 citations), Small Animals (46 citations) and Critical Care and Intensive Care Medicine (23 citations). Shirin Dashtbin has collaborated with scholars based in Iran and Iraq. Frequent co-authors include Roya Ghanavati, Marzie Mahdizade Ari, Kamran Tari, Ali Salimi Jeda, Mehdi Salari, Rokhsareh Mohammadzadeh, Ali Teimoori, Rasoul Yousefimashouf, Mohsen Heidary and Sima Kazemi. Their work appears in journals such as Journal of Clinical Laboratory Analysis, Future Microbiology, Frontiers in Pharmacology, Expert Review of Anti-infective Therapy and Journal of Health Population and Nutrition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.